Susanne Neumann Selected Research

Thyrotropin Receptors (Thyrotropin Receptor)

1/2022	Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays.
12/2020	Targeting TSH and IGF-1 Receptors to Treat Thyroid Eye Disease.
1/2020	TSH/IGF1 receptor crosstalk: Mechanism and clinical implications.
1/2020	β-Arrestin 1 in Thyrotropin Receptor Signaling in Bone: Studies in Osteoblast-Like Cells.
1/2019	Arrestin-β-1 Physically Scaffolds TSH and IGF1 Receptors to Enable Crosstalk.
10/2018	Stimulatory TSH-Receptor Antibodies and Oxidative Stress in Graves Disease.
1/2018	Evidence That Graves' Ophthalmopathy Immunoglobulins Do Not Directly Activate IGF-1 Receptors.
1/2017	Inhibiting thyrotropin/insulin-like growth factor 1 receptor crosstalk to treat Graves' ophthalmopathy: studies in orbital fibroblasts in vitro.
1/2016	An Enantiomer of an Oral Small-Molecule TSH Receptor Agonist Exhibits Improved Pharmacologic Properties.
1/2016	TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susanne Neumann Research Topics

Disease

14	Graves Ophthalmopathy 01/2022 - 08/2012
9	Graves Disease (Basedow Disease) 12/2020 - 11/2002
6	Hyperthyroidism 01/2022 - 12/2008
6	Thyroid Neoplasms (Thyroid Cancer) 01/2016 - 11/2002
3	Type 2 Diabetes Mellitus (MODY) 02/2008 - 06/2007
2	Thyroid Diseases (Thyroid Disease) 01/2014 - 11/2002
2	Hypothyroidism 08/2011 - 01/2004
2	Neoplasm Metastasis (Metastasis) 11/2009 - 11/2002
2	Goiter 05/2006 - 11/2003
1	Autoimmune Diseases (Autoimmune Disease) 12/2020
1	Multiple Sclerosis 11/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Stroke (Strokes) 01/2020
1	Infections 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Neuroinflammatory Diseases 01/2019
1	Ischemia 01/2016
1	Fibrous Dysplasia of Bone 01/2014
1	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 01/2014
1	Bullous Pemphigoid (Pemphigoid) 12/2010
1	Melanoma (Melanoma, Malignant) 11/2009
1	Neoplasms (Cancer) 11/2009
1	Diabetes Mellitus 06/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2007
1	Nonautoimmune Hyperthyroidism 05/2006
1	Thyroid Nodule (Nodule, Thyroid) 02/2004
1	Acromegaly 01/2004
1	Hyperparathyroidism 01/2004
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2004
1	Endemic Goiter 11/2003
1	Reactive Arthritis (Reiter Disease) 06/2003
1	Immune Reconstitution Inflammatory Syndrome 06/2003
1	Euthyroid Goiter 11/2002
1	Hyperaldosteronism (Conn Syndrome) 03/2002
1	Fibrosis (Cirrhosis) 03/2002
1	Obesity 01/2002
1	Insulin Resistance 01/2002

Drug/Important Bio-Agent (IBA)

18	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2022 - 02/2003
5	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2022 - 03/2015
5	AutoantibodiesIBA 01/2022 - 08/2012
4	AntibodiesIBA 01/2022 - 12/2008
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2002
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018 - 11/2009
4	Pharmaceutical PreparationsIBA 01/2016 - 10/2007
3	Hyaluronic Acid (Hyaluronan)IBA 01/2019 - 05/2013
3	Nonesterified Fatty Acids (NEFA)IBA 06/2008 - 06/2007
2	Thyroid HormonesIBA 12/2020 - 08/2011
2	Thyroid-Stimulating ImmunoglobulinsIBA 12/2020 - 02/2011
2	Insulin-Like PeptidesIBA 09/2020 - 01/2017
2	Thyrotropin Alfa FDA LinkGeneric 11/2009 - 07/2009
2	Insulin (Novolin)FDA Link 10/2007 - 01/2002
2	Glucose (Dextrose)FDA LinkGeneric 10/2007 - 03/2002
2	Proteins (Proteins, Gene)FDA Link 02/2004 - 01/2002
2	Thyroglobulin FDA Link 11/2003 - 11/2002
1	teprotumumabIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	tetraiodothyroacetic acid (TA(4))IBA 01/2019
1	Superoxides (Superoxide)IBA 10/2018
1	ZymosanIBA 10/2018
1	phorbolIBA 10/2018
1	2-hydroxyethidiumIBA 10/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	CaspasesIBA 01/2016
1	GTP-Binding Proteins (G-Protein)IBA 01/2014
1	Long-Acting Thyroid Stimulator (LATS)IBA 05/2013
1	FIBSIBA 08/2012
1	HLA-DR Antigens (HLA-DR)IBA 12/2010
1	Biological ProductsIBA 11/2009
1	EnzymesIBA 11/2009
1	Matrix Metalloproteinases (MMPs)IBA 11/2009
1	LigandsIBA 12/2008
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2008
1	Capsules (Microcapsules)IBA 03/2007
1	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2006
1	IodidesIBA 02/2004
1	sodium-iodide symporter (sodium iodide symporter)IBA 02/2004
1	Pentagastrin (Peptavlon)FDA Link 01/2004
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2004
1	Codon (Codons)IBA 01/2004
1	SymportersIBA 11/2003
1	IodineIBA 11/2003
1	Doxycycline (Periostat)FDA LinkGeneric 06/2003
1	RNA (Ribonucleic Acid)IBA 11/2002
1	AldosteroneIBA 03/2002
1	AdipokinesIBA 01/2002
1	Hormones (Hormone)IBA 01/2002
1	AdiponectinIBA 01/2002

Therapy/Procedure

2	Therapeutics 03/2015 - 11/2002
1	Ligation 01/2020
1	Radiotherapy 01/2020
1	Cranial Irradiation 01/2020
1	Transplantation 01/2019
1	Intradermal Injections 11/2009
1	Thyroidectomy 11/2002